Positive results from the first feasibility study of an advanced first-generation artificial pancreas system were presented at the 72nd Annual American Diabetes Association Meeting in Philadelphia. Findings from the study indicated that the Hypoglycemia-Hyperglycemia Minimizer (HHM) System… Read more
JDRF and Dexcom announced that they have formed a partnership whose goal is to accelerate the development of a novel wireless “smart transmitter” that would allow a continuous glucose monitor (CGM) system to communicate directly with an artificial pancreas… Read more
The U.S. Food and Drug Administration (FDA) has approved the first outpatient artificial pancreas trial in the United States, marking a critical development in the effort by JDRF and its allies to bring this innovative and lifesaving diabetes technology to people with type 1 diabetes… Read more
The U.S. Food and Drug Administration (FDA) issued draft guidance designed to help investigators and manufacturers as they develop and seek approval for artificial pancreas device systems to treat type 1 diabetes. This step comes after a large campaign led by the Juvenile Diabetes research Foundation … Read more
Diabetes technology has vastly improved in the last decade, and most people with diabetes who have the opportunity to wear an insulin pump or a continuous glucose monitor are grateful for the assistance they provide. But even with these advanced tools, the biggest burdens of diabetes – the insulin dosing and blood sugar testing – still lie on the person with diabetes or a caregiver. Read more
The artificial pancreas is better at controlling night time blood sugar levels than conventional pump therapy according to two knew studies carried out at the Wellcome Trust clinical research facility at Addenbrooke’s Hospital in England…. Read more
New research, funded by Diabetes UK, has found that use of an artificial pancreas by woman suffering from type 1 diabetes during pregnancy may drastically reduce cases of stillbirth and mortality rates… Read more
A panel of experts convened by the FDA and NIH to try to advance research and development of the artificial pancreas put forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations.
The experts are in agreement that even with the advanced treatments available today… Read more
Researchers from the University of California San Diego and GlySens Inc. have developed an implantable sensor that measures blood sugar continuously and transmits the information without wires, according to a Reuters report .
The device worked in one pig for more than a year and in another for nearly 10 months with no trouble, and the researchers hope to start a human study within a few months… Read more
The artificial pancreas is no longer the jet pack of diabetes, talked about for decades without ever coming to fruition… Read more